Loreen Natusch

Loreen Natusch

Auto-generated profile, based on publicly available information

Loreen Natusch

Department of Visceral, Thoracic and Vascular Surgery, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
NDNicole Dressel
Nicole Dressel
LNLoreen Natusch
Loreen Natusch
CMClara M. Munz
Clara M. Munz
SRSantiago Costas Ramon
Santiago Costas Ramon
MMMina Nabil Farid Morcos
Mina Nabil Farid Morcos
AGAlexander Gerbaulet
Alexander Gerbaulet
Genome damage is a main driver of malignant transformation, but it also induces aberrant inflammation via the cGAS/STING DNA-sensing pathway. Activation of cGAS/STING can trigger cell death and senescence, thereby potentially eliminating genome-damaged cells and preventing against malignant transformation. Here, we report that defective ribonucleotide excision repair (RER) in the hematopoietic system caused genome instability with concomitant activation of the cGAS/STING axis and compromised hematopoietic stem cell function, ultimately resulting in leukemogenesis. Additional inactivation of cGAS, STING, or type I IFN signaling, however, had no detectable effect on blood cell generation and leukemia development in RER-deficient hematopoietic cells. In wild-type mice, hematopoiesis under steady-state conditions and in response to genome damage was not affected by loss of cGAS. Together, these data challenge a role of the cGAS/STING pathway in protecting the hematopoietic system against DNA damage and leukemic transformation. Significance: Loss of cGAS/STING signaling does not impact DNA damage–driven leukemogenesis or alter steady-state, perturbed or malignant hematopoiesis, indicating that the cGAS/STING axis is not a crucial antioncogenic mechanism in the hematopoietic system. See related commentary by Zierhut, p. 2807

28 October 2025 in iScience
Verified
Journal Article
Open access
DDDavid Digomann
David Digomann
CRCharlotte Reiche
Charlotte Reiche
ASAntonia Stammberger
Antonia Stammberger
TWTido Willms
Tido Willms
LRLoreen S. Rudek
Loreen S. Rudek
ASAdrian Seifert
Adrian Seifert
Current biomarkers for diagnosis and prognosis prediction in gastric cancer (GC) and gastroesophageal junction (GEJ) cancer have limited accuracy, and the role of soluble immune checkpoints is unknown. In this study, T cell immunoglobulin and mucin domain-containing-3 (TIM-3) and galectin-9 expression was investigated in single-cell RNA (scRNA) sequencing data and with multiplex immunohistochemistry. Further, serum samples from 310 patients with GC/GEJ and 82 healthy donors were analyzed for soluble TIM-3 (sTIM-3) and galectin-9 (sGal-9). sGal-9 levels were significantly increased in patients with cancer compared to healthy donors (p < 0.001). Notably, the combination of sTIM-3 and sGal-9 had a higher diagnostic accuracy for GC/GEJ than the established tumor markers CEA, CA19-9, and CA72-4. Patients with GC/GEJ with increased sTIM-3 and sGal-9 levels had a significantly reduced overall survival with a hazard ratio of 1.77 (sTIM-3 high), 1.82 (sGal-9 high), and 2.27 (sTIM-3 high+sGal-9 high), respectively. Collectively, sTIM-3 and sGal-9 may serve as novel non-invasive biomarkers for diagnosis and outcome prediction in patients with GC/GEJ.

5 November 2025 in OncoImmunology
Verified
Journal Article
Open access
FBFranziska Baenke
Franziska Baenke
ASAntonia Stammberger
Antonia Stammberger
USUlrich Sommer
Ulrich Sommer
SBSascha Brückmann
Sascha Brückmann
FMFelix Merboth
Felix Merboth
ASAdrian Seifert
Adrian Seifert
Gastroesophageal junction (GEJ) adenocarcinoma is an increasingly common cancer with complex biology and poor prognosis. The treatment strategy for locally advanced tumors involves multimodal treatment with perioperative chemotherapy. However, survival rates remain low, especially for advanced disease. Here, formalin-fixed paraffin-embedded tumor sections from 72 patients with GEJ I and II adenocarcinoma who underwent primary resection or perioperative standard-of-care FLOT treatment were analyzed for their intratumoral T cell composition using multiplex immunohistochemistry. The proportions of T cells and their influence on survival were evaluated using Mann-Whitney U and log rank analyses. A comparison of short- and long-term survivors revealed significant differences in the infiltration of regulatory T cells (Tregs). Tumors after neoadjuvant FLOT treatment presented increased proportions of CD8+ T cells with reduced Granzyme B expression, indicating an altered immune response. Overall survival analysis revealed that high infiltration of Tregs was associated with poor survival. Notably, responders to FLOT therapy had a greater T cell frequency and improved survival, whereas nonresponders presented higher levels of Tregs and CD8+ T cells expressing TIM-3. Overall, GEJ cancer patients had increased CD8+ T cells after neoadjuvant chemotherapy with FLOT, and Tregs were associated with treatment response and reduced survival.

24 November 2025
Verified
Other
Open access
NDNicole Dressel
Nicole Dressel
LNLoreen Natusch
Loreen Natusch
CMClara M. Munz
Clara M. Munz
SRSantiago Costas Ramon
Santiago Costas Ramon
MMMina Nabil Farid Morcos
Mina Nabil Farid Morcos
AGAlexander Gerbaulet
Alexander Gerbaulet
Supplementary Figures S1-8 and corresponding figure legends

16 September 2024
Verified
Other
Open access
PDF file
NDNicole Dressel
Nicole Dressel
LNLoreen Natusch
Loreen Natusch
CMClara M. Munz
Clara M. Munz
SRSantiago Costas Ramon
Santiago Costas Ramon
MMMina Nabil Farid Morcos
Mina Nabil Farid Morcos
AGAlexander Gerbaulet
Alexander Gerbaulet
Supplementary Figures S1-8 and corresponding figure legends

16 September 2024
Verified
Other
Open access
NDNicole Dressel
Nicole Dressel
LNLoreen Natusch
Loreen Natusch
CMClara M. Munz
Clara M. Munz
SRSantiago Costas Ramon
Santiago Costas Ramon
MMMina Nabil Farid Morcos
Mina Nabil Farid Morcos
AGAlexander Gerbaulet
Alexander Gerbaulet
Supplementary Tables S3-5 from Activation of the cGAS/STING axis in genome-damaged hematopoietic cells does not impact blood cell formation or leukemogenesis